Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for HCAT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 100.83M
March 31, 2026 138.14M
December 31, 2025 245.78M
September 30, 2025 331.92M
June 30, 2025 347.55M
March 31, 2025 376.81M
December 31, 2024 365.21M
September 30, 2024 355.04M
June 30, 2024 357.00M
March 31, 2024 357.21M
December 31, 2023 366.92M
September 30, 2023 382.39M
June 30, 2023 389.87M
March 31, 2023 405.15M
December 31, 2022 425.01M
September 30, 2022 439.97M
June 30, 2022 469.06M
March 31, 2022 480.91M
Date Value
December 31, 2021 522.10M
September 30, 2021 549.21M
June 30, 2021 275.90M
March 31, 2021 268.84M
December 31, 2020 276.10M
September 30, 2020 299.62M
June 30, 2020 233.96M
March 31, 2020 204.12M
December 31, 2019 200.64M
September 30, 2019 206.55M
June 30, 2019 27.42M
March 31, 2019 35.90M
December 31, 2018 35.08M
September 30, 2018
June 30, 2018
March 31, 2018
December 31, 2017 62.09M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
LataMed AI Corp. 7.053M
SCWorx Corp. 6.932M
GoodRx Holdings, Inc. 647.60M
Claritev Corp. -294.56M
iSpecimen, Inc. 1.736M

Shareholders Equity (Quarterly) Related Metrics